[go: up one dir, main page]

BR9809712A - Formas de dosagem de sertralina em solução encapsulada de gelatina - Google Patents

Formas de dosagem de sertralina em solução encapsulada de gelatina

Info

Publication number
BR9809712A
BR9809712A BR9809712-1A BR9809712A BR9809712A BR 9809712 A BR9809712 A BR 9809712A BR 9809712 A BR9809712 A BR 9809712A BR 9809712 A BR9809712 A BR 9809712A
Authority
BR
Brazil
Prior art keywords
sertraline
dosage forms
gelatin solution
encapsulated
encapsulated gelatin
Prior art date
Application number
BR9809712-1A
Other languages
English (en)
Inventor
William John Curatolo
Ravi Mysone Shanker
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971076&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9809712(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR9809712A publication Critical patent/BR9809712A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Addiction (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Patente de Invenção: <B>''FORMAS DE DOSAGEM DE SERTRALINA EM SOLUçãO ENCAPSULADA DE GELATINA''<D>. Formas de dosagem da sertralina encapsuladas em veículos imiscíveis em água, diminuem o T~ max~ e/ou reduzem os efeitos secundários da precipitação da sertralina em meios de utilização contendo o íon cloreto, tais como o trato gastrintestinal.
BR9809712-1A 1997-07-01 1998-06-16 Formas de dosagem de sertralina em solução encapsulada de gelatina BR9809712A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5140197P 1997-07-01 1997-07-01
PCT/IB1998/000936 WO1999001113A1 (en) 1997-07-01 1998-06-16 Gelatine encapsulated solution dosage forms of sertraline

Publications (1)

Publication Number Publication Date
BR9809712A true BR9809712A (pt) 2000-07-11

Family

ID=21971076

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809712-1A BR9809712A (pt) 1997-07-01 1998-06-16 Formas de dosagem de sertralina em solução encapsulada de gelatina

Country Status (40)

Country Link
EP (1) EP0980241B1 (pt)
JP (1) JP3585245B2 (pt)
KR (1) KR100371730B1 (pt)
CN (1) CN1261792A (pt)
AP (1) AP945A (pt)
AR (1) AR015916A1 (pt)
AT (1) ATE256457T1 (pt)
AU (1) AU724635B2 (pt)
BG (1) BG103917A (pt)
BR (1) BR9809712A (pt)
CA (1) CA2290973C (pt)
CO (1) CO4940405A1 (pt)
DE (1) DE69820608T2 (pt)
DK (1) DK0980241T3 (pt)
DZ (1) DZ2544A1 (pt)
EA (1) EA001905B1 (pt)
ES (1) ES2210760T3 (pt)
GT (1) GT199800090A (pt)
HR (1) HRP980378B1 (pt)
HU (1) HUP0002250A3 (pt)
ID (1) ID24673A (pt)
IL (1) IL133075A0 (pt)
IS (1) IS5266A (pt)
MA (1) MA24586A1 (pt)
MY (1) MY119728A (pt)
NO (1) NO996492L (pt)
NZ (1) NZ501252A (pt)
OA (1) OA11246A (pt)
PA (1) PA8454001A1 (pt)
PE (1) PE97299A1 (pt)
PL (1) PL337807A1 (pt)
PT (1) PT980241E (pt)
SK (1) SK282914B6 (pt)
TN (1) TNSN98123A1 (pt)
TR (1) TR199903282T2 (pt)
TW (1) TW382597B (pt)
UA (1) UA68350C2 (pt)
UY (1) UY25070A1 (pt)
WO (1) WO1999001113A1 (pt)
ZA (1) ZA985709B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL348119A1 (en) * 1998-10-13 2002-05-06 Pfizer Prod Inc Sertraline oral concentrate
US6727283B2 (en) 1998-10-13 2004-04-27 Pfizer Inc. Sertraline oral concentrate
DE60026146T2 (de) 1999-09-03 2006-08-17 Apbi Holdings, Llc Verwendung von Dapoxetin, A selektiver Serotonin Aufnahme Inhibitor mit schnellem Wirkungseintritt, zur Behandlung von sexueller Disfunktion
CA2420535A1 (en) 2000-08-30 2002-03-07 Mary Tanya Am Ende Sustained release formulations for growth hormone secretagogues
EP1375659A1 (en) * 2002-06-18 2004-01-02 Laboratorio di Diagnostica Moleculare Soluble capsules containing stock mixtures for easy preparation of chemical or biological solutions
EP1556000A1 (en) * 2002-10-31 2005-07-27 Alza Corporation Pharmaceutical formulation providing an increased biovailability of hydrophobic drugs
WO2016020936A2 (en) * 2014-07-21 2016-02-11 Patel Jayendrakumar Dasharathlal A novel oral gastroretentive pharmaceutical dosage form
CN108014087A (zh) * 2017-12-27 2018-05-11 江苏联环药业股份有限公司 一种盐酸舍曲林胶囊的制备方法
GB2630572A (en) 2023-05-29 2024-12-04 Novumgen Ltd An orally disintegrating tablet of sertraline and its process of preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69525847T2 (de) * 1994-09-19 2002-09-05 Dupont Pharmaceuticals Co., Wilmington Zusammensetzungen von opioid antagonisten mit selektiven serotonin-aufnahme inhibitoren, zur behandlung von alkoholismus und alkohoabhängigkeit
DE69626916T2 (de) * 1995-07-17 2003-10-09 Pfizer Inc., New York Sertralin zur Behandlung von Post-Myocard-Infarkt-Patienten

Also Published As

Publication number Publication date
KR20010013588A (ko) 2001-02-26
MA24586A1 (fr) 1998-12-31
OA11246A (en) 2002-11-19
EP0980241A1 (en) 2000-02-23
NO996492L (no) 2000-02-29
HRP980378B1 (en) 2001-12-31
PE97299A1 (es) 1999-10-13
IL133075A0 (en) 2001-03-19
HUP0002250A2 (hu) 2000-12-28
UA68350C2 (en) 2004-08-16
JP2000512316A (ja) 2000-09-19
HRP980378A2 (en) 1999-04-30
PL337807A1 (en) 2000-09-11
TNSN98123A1 (fr) 2005-03-15
EA001905B1 (ru) 2001-10-22
EP0980241B1 (en) 2003-12-17
AP945A (en) 2001-02-28
TR199903282T2 (xx) 2000-08-21
CA2290973A1 (en) 1999-01-14
KR100371730B1 (ko) 2003-02-07
DE69820608D1 (de) 2004-01-29
TW382597B (en) 2000-02-21
HUP0002250A3 (en) 2001-01-29
EA199900963A1 (ru) 2000-08-28
AU724635B2 (en) 2000-09-28
ID24673A (id) 2000-07-27
DZ2544A1 (fr) 2003-02-08
NZ501252A (en) 2004-11-26
AR015916A1 (es) 2001-05-30
ZA985709B (en) 2000-01-10
ES2210760T3 (es) 2004-07-01
PT980241E (pt) 2004-03-31
JP3585245B2 (ja) 2004-11-04
BG103917A (bg) 2000-07-31
ATE256457T1 (de) 2004-01-15
SK282914B6 (sk) 2003-01-09
NO996492D0 (no) 1999-12-27
DK0980241T3 (da) 2004-04-05
IS5266A (is) 1999-11-23
CO4940405A1 (es) 2000-07-24
CN1261792A (zh) 2000-08-02
AP9801279A0 (en) 1998-06-30
CA2290973C (en) 2003-06-17
PA8454001A1 (es) 2000-05-24
MY119728A (en) 2005-07-29
UY25070A1 (es) 2000-12-29
GT199800090A (es) 1999-12-21
SK180599A3 (en) 2001-01-18
DE69820608T2 (de) 2004-12-23
AU7545098A (en) 1999-01-25
WO1999001113A1 (en) 1999-01-14

Similar Documents

Publication Publication Date Title
FI973419A0 (fi) Epäorgaanisten aerogeelien käyttö lääkkeiden valmistuksessa
BR9710994A (pt) Derivados anticonvulsivos úteis no tratamento de obesidade.
PT1083889E (pt) Compostos de tetra-hidronaftaleno e sua utilizacao no tratamento de doencas neurodegenerativas
FR2784294B1 (fr) Composition cosmetique et/ou dermatologique renfermant au moins un extrait de murier, au moins un extrait de scutellaire et au moins un derive d&#39;acide salicylique
CA2333145A1 (en) Drug delivery system comprising a homeobox peptide and a non-peptide, non-nucleotide drug
PT848720E (pt) Antagonistas da actividade oncogenica da proteina mdm2 e sua utilizacao no tratamento de cancros
GEP20063818B (en) Orodispersible pharmaceutical composition comprising agomelatine
EP1053315A4 (en) HUMAN &#39;HAARLOS&#39; GENE AND PROTEIN AND THEIR USE
DE69905170T2 (de) Thiazolopyrimidinderivate
ES2168457T3 (es) Composiciones farmaceuticas que comprenden una superoxido dismutasa.
BR9914674A (pt) Grânulo matriz
BR9809712A (pt) Formas de dosagem de sertralina em solução encapsulada de gelatina
EP0853486A4 (en) THERAPEUTIC USE OF ANIMAL SERUMS, ESPECIALLY HORSES, FOR THE TREATMENT OF AIDS, CANCER AND OTHER VIRAL AND BACTERIAL DISEASES
EP0853486A3 (en) Therapeutic applications of animal sera including horse serum in the treatment of aids, cancer, and other viral and bacterial diseases
ITRM930291A0 (it) Procedimento per la preparazione di biopolimeri iodurati con attivita&#39;disinfettante e cicatrizzante, e biopolimeri iodurati cosi&#39; ottenuti.
GEP20063820B (en) Orodispersible pharmaceutical composition comprising ivabradine
DE69939075D1 (de) Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten
DE69725754D1 (de) Eingekapselte Antikörper-produzierende Zellen
GEP20063821B (en) Orodispersible pharmaceutical composition comprising perindopril
IT1292396B1 (it) Cerotto dermico avente elevata resistenza meccanica,flessibilita&#39; trasparenza e conducibilita&#39; elettrica nel trattamento di affezioni
GB9929497D0 (en) Improved amino acid mixtures for the treatment and/or management of certain diseases
WO1998031712A3 (en) Chitosan-conjugates with acidic chelate-complex forming agents
EA200000875A1 (ru) Белки, взаимодействующие с каспазой-8
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
BR9914722A (pt) Derivados de anticonvulsivo úteis no tratamento de dependência, vìcio e abuso do álcool

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 36 DA LPI .